Business / Finance

RSS

Genentech agrees to acquire Seragon Pharmaceuticals

Genentech, a member of the Roche Group, today announced it has entered into a definitive agreement to acquire Seragon Pharmaceuticals, Inc., a privately held biotechnology company based in San Diego, California.

2 Jul 2014

Rotation Medical secures $27.2 million in oversubscribed Series B financing

Rotation Medical, a medical device company focused on developing new technologies to treat rotator cuff disease, today announced that it has secured $27.2 million in an oversubscribed Series B financing.

1 Jul 2014

Telerx acquires C3i to expand business services outside the United States

Telerx, a leader in U.S. customer care services, today announced that it has completed its acquisition of C3i, a leading provider of technology support services for the life sciences industry. This acquisition will provide Telerx with the global infrastructure to expand its business services outside the United States while maintaining its current domestic operations. The acquisition was completed on June 30, 2014.

1 Jul 2014

Cerus enters into $30M growth capital credit facility with Oxford Finance

Cerus Corporation announced today that it has entered into a $30 million growth capital credit facility with Oxford Finance LLC.

1 Jul 2014

Capital Senior Living purchases three communities, closes debt refinance

Capital Senior Living Corporation (the "Company"), one of the country's largest operators of senior living communities, today announced that the Company has purchased three senior living communities located in Ohio from joint ventures in which it held a 10 percent interest (the "Ohio JV Communities") for a purchase price of $83.6 million.

1 Jul 2014

PuriCore International acquired by Cantel Medical

Cantel Medical Corp., today announced that the company has successfully completed the acquisition of PuriCore International Limited., a wholly-owned subsidiary of PuriCore plc.

1 Jul 2014

FSC Laboratories acquires exclusive marketing rights for Aciphex Sprinkle in the U.S.

FSC Therapeutics, LLC, today announced that the Company has entered into a transaction with Eisai Inc. to acquire exclusive U.S. marketing rights for AcipHex® Sprinkle™ (rabeprazole sodium), Delayed-Release Capsules, 5 mg and 10 mg, for the treatment of Gastroesophageal Reflux Disease (GERD) in children 1 to 11 years of age for up to 12 weeks.

30 Jun 2014

Medican Enterprises is in negotiations to purchase 51% of International Herbs Medical Marijuana

Medican Enterprises, Inc. a bio-pharmaceutical company in the emerging global medical marijuana industry is pleased to announce it is currently negotiating the purchase of 51% of International Herbs Medical Marijuana Ltd ("IHMML").

30 Jun 2014

Stryker Corporation to acquire all assets of Small Bone Innovations for $375M

Small Bone Innovations, Inc. (SBi) today announced that Stryker Corporation will acquire substantially all the assets of SBi in an all cash transaction for up to $375 million.

From Stryker 30 Jun 2014

Cidara Therapeutics closes $32M Series A financing to advance novel echinocandin antifungal drug

Cidara Therapeutics, Inc., a privately held biopharmaceutical company, announced today that it has completed a $32 million Series A financing that will enable it to advance candidates from the company's Cloudbreak™ targeted immunotherapy platform and biafungin™, a novel long acting echinocandin antifungal drug, into human clinical studies.

30 Jun 2014

Glenridge HealthCare Solutions acquired by WhiteGlove Health

WhiteGlove Health, Inc., a leading chronic care and population health management provider, announced the acquisition of Glenridge HealthCare Solutions, a premier provider of technology-enabled network development and consulting services.

30 Jun 2014

AMSURG offers $880M aggregate principal amount of senior unsecured notes due 2022

AMSURG Corp. today announced that it has launched its offering of approximately $880 million aggregate principal amount of senior unsecured notes due 2022 (the "Notes").

30 Jun 2014

Affimed Therapeutics files Form F-1 registration statement for public offering of common stock

Affimed Therapeutics today announced that it has filed a registration statement on Form F-1 with the U.S. Securities and Exchange Commission ("SEC") relating to a proposed initial public offering of its common shares.

30 Jun 2014

MagForce publishes operative highlights and financial results for fiscal year 2013

MagForce AG, a leading medical device company in the field of nanomedicine focused on oncology, published today its financial results for the fiscal year ending on December 31, 2013 and operative highlights.

30 Jun 2014

IXICO and VirtualScopics jointly lease office space in New Hope, Pennsylvania

VirtualScopics, Inc., a leading provider of clinical trial imaging solutions, and IXICO plc (AIM: IXI), the brain health company, announced today they are jointly leasing 2,190 sq. ft. of office space in New Hope, Pennsylvania, strategically located within the big pharma corridor that runs through New Jersey and Pennsylvania.

30 Jun 2014

Helsinn Group grants GEN Ilaç anamorelin rights for Turkey

Helsinn Group, the company focused on building quality cancer care, today announces that rights to anamorelin, its innovative ghrelin receptor agonist, have been granted in Turkey to GEN Ilaç.

30 Jun 2014

ARC Healthcare to continue payment of monthly distributions at $0.68 per share

American Realty Capital Healthcare Trust, Inc. ("ARC Healthcare") announced today that, pursuant to the prior authorization of its board of directors, ARC Healthcare intends to continue payment of monthly distributions at an annualized rate of $0.68 per share.

28 Jun 2014

Valent Biosciences opens new biorational manufacturing facility in Iowa

Valent BioSciences Corporation (VBC) today marked the official opening of its new $146 million biorational manufacturing facility in Osage, IA in a ceremony that included more than 130 international dignitaries, state and local VIPs, and media personnel.

28 Jun 2014

Kerr acquires DUX Dental and Vettec to expand product portfolio

Kerr Corporation, a global manufacturer of dental products, announced today that it has acquired DUX Dental and Vettec Inc. to further expand its product portfolio and to better serve dental professionals and healthcare providers globally.

28 Jun 2014

China Biologic prices follow-on offering of common stock at $38.00 per share

China Biologic Products, Inc., a leading plasma-based biopharmaceutical company in China, today announced the pricing of a follow-on offering of 1,550,000 shares of common stock at a public offering price of $38.00 per share.

27 Jun 2014